Antioxidant peptides with angiotensin converting enzyme inhibitory activities and applications for angiotensin converting enzyme purification

Journal of Agricultural and Food Chemistry

Volumn 51, Issue 6, 2003, Pages 1706-1709

  Hou, Wen Chi ^a   Chen, Hsien Jung ^b   Lin, Yaw Huei ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINESE CULTURE UNIVERSITY   (Taiwan)

^c INSTITUTE OF PLANT AND MICROBIAL BIOLOGY   (Taiwan)

Author keywords

Angiotensin converting enzyme (ACE); EAH activated gel; Glutathione; N 3 (2 furyl)acryloyl Phe Gly Gly (FAPGG); Peptide

Indexed keywords

ANTIOXIDANT; CAPTOPRIL; CARNOSINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE; N [3 (2 FURYL)ACRYLOYL]PHENYLALANYLGLYCYLGLYCINE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; IC 50;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; CARNOSINE; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, AGAROSE; CYANOGEN BROMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; KINETICS; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; SPECTROPHOTOMETRY;

EID: 0037433480     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0260242     Document Type: Article

References (34)

1. Mark, K. S.; Davis, T. P. Stroke: development, prevention and treatment with peptidase inhibitors. Peptides 2000, 21, 1965-1973.
2. Dunbabin, D. Cost-effective intervention in stroke. Pharmacoeconomics 1992, 2, 468-499.
3. Fotherby, M. D.; Panayiotou, B. Antihypertensive therapy in the prevention of stroke: what, when, and for whom? Drugs 1999, 58, 663-674.
4. Mullally, M. M.; Meisel, H.; FitzGerald, R. J. Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. 1996, 377, 259-260.
5. Ariyoshi, Y. Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci. Technol. 1993, 4, 139-144.
6. Pihlanto-Leppälä, A.; Rokka, T.; Korhonen, H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int. Dairy J. 1998, 8, 325-331.
7. Pihlanto-Leppälä, A.; Koskinen, P.; Piilola, K.; Tupasela, T.; Korhonen, H. Angiotensin I-converting enzyme inhibitory properties of whey protein digest: concentration and characterization of active peptides. J. Dairy Res. 2000, 67, 53-64.
8. Pihlanto-Leppälä, A. Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci. Technol. 2001, 11, 347-356.
9. sl-casein. Agric. Biol. Chem. 1987, 51, 2557-2561.
10. Kohmura, M.; Nio, N.; Kubo, K.; Minoshima, Y.; Munekata, E.; Ariyoshi, Y. Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein. Agric. Biol. Chem. 1989, 53, 2107-2114.
11. Maeno, M.; Yamamoto, N.; Takano, T. Identification of an antihypertensivepeptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 1996, 79, 1316-1321.
12. Miyoshi, S.; Ishikawa, H.; Kaneko, T.; Fukui, F.; Tanaka, H.; Maruyama, S. Structures and activity of angiotensin-converting enzyme inhibitors in an α-zein hydrolysate. Agric. Biol. Chem. 1991, 55, 1313-1318.
13. Yano, S.; Suzuki, K.; Funatsu, G. Isolation from α-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity. Biosci., Biotechnol., Biochem. 1996, 60, 661-663.
14. Chen, T. L.; Ken, K. S.; Chang, H. M. Study on the preparation of angiotensin-converting enzyme inhibitors (ACEI) from hydrolysates of gelatin. J. Chin. Agric. Chem. Soc. 1999, 37, 546-553.
15. Hsu, F. L.; Lin, Y. H.; Lee, M. H.; Lin, C. L.; Hou, W. C. Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1), and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities. J. Agric. Food Chem. 2002, 50, 6109-6113.
16. Smith, C. V.; Jones, D. P.; Guenthner, T. M.; Lash, L. H.; Lauterburg, B. H. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol. Appl. Pharmacol. 1996, 140, 1-12.
17. Noctor, G.; Foyer, C. H. Ascorbate and glutathione: keeping active oxygen under control. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1998, 49, 247-279.
18. Sies, H. Glutathione and its role in cellular functions. Free Radical Biol. Med. 1999, 27, 916-921.
19. Schafer, F. Q.; Buettner, G. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biol. Med. 2001, 30, 1191-1212.
20. Brownson, C.; Hipkiss, A. R. Carnosine reacts with a glycated protein. Free Radical Biol. Med. 2000, 28, 1564-1570.
21. Kohen, R.; Yamamoto, Y.; Cundy, K. C.; Ames, B. N. Antioxidant activity of camosine, homocarnosine and anserine present in muscle and brain. Proc. Natl. Acad. Sci. U.S.A. 1988, 95, 2175-2179.
22. McFarland, G. A.; Holliday, R. Retardation of the senescence of cultured human diploid fibroblasts by camosine. Exp. Cell Res. 1994, 212, 167-175.
23. Peretto, P.; Luzzati, F.; Bonfanti, L.; Marchis, S. D.; Fasolo, A. Aminoacyl-histidine dipeptides in the glial cells of the adult rabbit forebrain. Peptides 2000, 21, 1717-1724.
24. Holmquist, B.; Bunning, P.; Riordan, J. F. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal. Biochem. 1979, 95, 540-548.
25. Matsui, T.; Li, C. H.; Tanaka, T.; Maki, T.; Osajima, Y.; Matsumoto, K. Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol. Pharm. Bull. 2000, 23, 427-431.
26. Fujita, H.; Yokoyama, K.; Yoshikawa, M. Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J. Food Sci. 2000, 65, 564-569.
27. Yoshii, H.; Tachi, N.; Ohba, R.; Sakamura, O.; Takeyama, H.; Itani, T. Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks. Comp. Biochem. Physiol. C 2001, 128, 27-33.
28. Matsui, T.; Tamaya, K.; Seki, E.; Osajima, K.; Matsumoto, K.; Kawasaki, T. Absorption of Val-Tyr with in vitro angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects. Biol. Pharm. Bull. 2002, 25, 1228-1230.
29. Pantoliano, M. W.; Holmquist, B.; Riordan, J. F. Affinity chromatographic purification of angiotensin converting enzyme. Biochemistry 1984, 23, 1037-1042.
30. Bull, H. G.; Thomberry, N. A.; Cordes, E. H. Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. J. Biol. Chem. 1985, 260, 2963-2972.
31. Lanzillo, J. J.; Stevens, J.; Dasarathy, Y.; Yotsumoto, H.; Fanburg, B. L. Angiotensin-converting enzyme from human tissues. Physicochemical, catalytic, and immunological properties. J. Biol. Chem. 1985, 260, 14938-14944.
32. Taira, H.; Mizutani, S.; Narita, O.; Tomoda, Y. Angiotensin I-converting enzyme in human placenta. Placenta 1985, 6, 543-549.
33. Ryan, J. W. Angiotensin-converting enzyme, dipeptidyl carboxy-peptidase I, and its inhibitors. Methods Enzymol. 1988, 163, 194-209.
34. Polanco, M. J.; Agapito, M. T.; Recio, J. M. Inhibition and affinity chromatography of chicken lung angiotensin I-converting enzyme with captopril. Comp. Biochem. Physiol. B: Comp. Biochem. 1992, 102, 527-533.